Terms: = Germ cell tumor AND BCL2, Bcl-2, 596, ENSG00000171791 AND Clinical Outcome
37 results:
1. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft cell Carcinoma.
Koh J; Kim H; Moon KC; Lee C; Lee K; Ryu HS; Jung KC; Jeon YK
Am J Surg Pathol; 2023 Feb; 47(2):183-193. PubMed ID: 36253891
[TBL] [Abstract] [Full Text] [Related]
2. SOCS5 contributes to temozolomide resistance in glioblastoma by regulating bcl-2-mediated autophagy.
Yu J; Han L; Yang F; Zhao M; Zhou H; Hu L
Bioengineered; 2022 Jun; 13(6):14125-14137. PubMed ID: 35730472
[TBL] [Abstract] [Full Text] [Related]
3. Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
Knispel S; Stang A; Zimmer L; Lax H; Gutzmer R; Heinzerling L; Weishaupt C; Pföhler C; Gesierich A; Herbst R; Kaehler KC; Weide B; Berking C; Loquai C; Utikal J; Terheyden P; Kaatz M; Schlaak M; Kreuter A; Ulrich J; Mohr P; Dippel E; Livingstone E; Becker JC; Weichenthal M; Chorti E; Gronewold J; Schadendorf D; Ugurel S
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32371460
[TBL] [Abstract] [Full Text] [Related]
4. BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma.
Sime W; Niu Q; Abassi Y; Masoumi KC; Zarrizi R; Køhler JB; Kjellström S; Lasorsa VA; Capasso M; Fu H; Massoumi R
Cell Death Dis; 2018 May; 9(5):458. PubMed ID: 29686263
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of G-protein-coupled receptors 65 in glioblastoma predicts poor patient prognosis.
Wang HX; Chen YH; Zhou JX; Hu XY; Tan C; Yan Y; Huang QL; Shen JY; Xu HC; Li F; Gong ZY; Xu T; Chen JX
Clin Neurol Neurosurg; 2018 Jan; 164():132-137. PubMed ID: 29223793
[TBL] [Abstract] [Full Text] [Related]
6. The Relationship Between Apoptotic Activity and Prognostic Factors in Neuroblastomas.
Ekmekci S; Olgun N; Özer E
Turk Patoloji Derg; 2016; 32(2):99-104. PubMed ID: 27136108
[TBL] [Abstract] [Full Text] [Related]
7. p53 upregulated modulator of apoptosis sensitizes drug-resistant U251 glioblastoma stem cells to temozolomide through enhanced apoptosis.
Miao W; Liu X; Wang H; Fan Y; Lian S; Yang X; Wang X; Guo G; Li Q; Wang S
Mol Med Rep; 2015 Jun; 11(6):4165-73. PubMed ID: 25625235
[TBL] [Abstract] [Full Text] [Related]
8. Merkel cell carcinoma: mitoses, expression of Ki-67 and bcl-2 correlate with disease progression.
Vujic I; Marker M; Posch C; Mühlehner D; Monshi B; Breier F; Steiner A; Ortiz-Urda S; Rappersberger K
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):542-8. PubMed ID: 25088273
[TBL] [Abstract] [Full Text] [Related]
9. Solitary fibrous tumor of the central nervous system: report of 2 cases and review of literature.
Wen G; Li M; Xu L; Hu P; Liao X; Lin C; Zhao L
Int J Clin Exp Pathol; 2014; 7(6):3444-8. PubMed ID: 25031774
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.
Ryan J; Tivnan A; Fay J; Bryan K; Meehan M; Creevey L; Lynch J; Bray IM; O'Meara A; Tracey L; Davidoff AM; Stallings RL
Br J Cancer; 2012 Sep; 107(6):967-76. PubMed ID: 22892391
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.
Wang Y; Chen L; Bao Z; Li S; You G; Yan W; Shi Z; Liu Y; Yang P; Zhang W; Han L; Kang C; Jiang T
Oncol Rep; 2011 Nov; 26(5):1173-80. PubMed ID: 21887474
[TBL] [Abstract] [Full Text] [Related]
12. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
[TBL] [Abstract] [Full Text] [Related]
13. Medulloblastomas: a correlative study of MIB-1 proliferation index along with expression of c-Myc, ERBB2, and anti-apoptotic proteins along with histological typing and clinical outcome.
Das P; Puri T; Suri V; Sharma MC; Sharma BS; Sarkar C
Childs Nerv Syst; 2009 Jul; 25(7):825-35. PubMed ID: 19444455
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas.
Snuderl M; Chi SN; De Santis SM; Stemmer-Rachamimov AO; Betensky RA; De Girolami U; Kieran MW
J Neuropathol Exp Neurol; 2008 Sep; 67(9):911-20. PubMed ID: 18716553
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract] [Full Text] [Related]
16. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
[TBL] [Abstract] [Full Text] [Related]
17. In melanoma changes of immature and mature dendritic cell expression correlate with tumor thickness:an immunohistochemical study.
Simonetti O; Goteri G; Lucarini G; Rubini C; Stramazzotti D; Lo Muzio L; Biagini G; Offidani A
Int J Immunopathol Pharmacol; 2007; 20(2):325-33. PubMed ID: 17624244
[TBL] [Abstract] [Full Text] [Related]
18. Gemistocytes in astrocytomas: are they a significant prognostic factor?
Martins DC; Malheiros SM; Santiago LH; Stávale JN
J Neurooncol; 2006 Oct; 80(1):49-55. PubMed ID: 16645716
[TBL] [Abstract] [Full Text] [Related]
19. Ki-67, bcl-2 and p53 expression in primary and metastatic melanoma.
Ilmonen S; Hernberg M; Pyrhönen S; Tarkkanen J; Asko-Seljavaara S
Melanoma Res; 2005 Oct; 15(5):375-81. PubMed ID: 16179864
[TBL] [Abstract] [Full Text] [Related]
20. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:bcl-2 ratio and preventing proteolytic activities.
Das A; Banik NL; Patel SJ; Ray SK
Mol Cancer; 2004 Dec; 3(1):36. PubMed ID: 15588281
[TBL] [Abstract] [Full Text] [Related]
[Next]
